地诺单抗、类风湿关节炎中的皮质骨与骨侵蚀 - Suppr

Suppr

超能文献

Denosumab, cortical bone and bone erosions in rheumatoid arthritis.

作者信息

Rossini Maurizio, Adami Giovanni, Viapiana Ombretta, Idolazzi Luca, Gatti Davide

机构信息

Rheumatology Section, Department of Medicine, University of Verona, Verona, Italy.

出版信息

Ann Rheum Dis. 2016 Oct;75(10):e70. doi: 10.1136/annrheumdis-2016-210022. Epub 2016 Jun 23.

DOI:10.1136/annrheumdis-2016-210022

PMID:27338779

Abstract

摘要

相似文献

Denosumab, cortical bone and bone erosions in rheumatoid arthritis.地诺单抗、类风湿关节炎中的皮质骨与骨侵蚀

Ann Rheum Dis. 2016 Oct;75(10):e70. doi: 10.1136/annrheumdis-2016-210022. Epub 2016 Jun 23.

Response to: 'Denosumab, cortical bone and bone erosion in rheumatoid arthritis' by Rossini et al.对Rossini等人所著的《地诺单抗、皮质骨与类风湿关节炎中的骨侵蚀》的回应

Ann Rheum Dis. 2016 Oct;75(10):e71. doi: 10.1136/annrheumdis-2016-210027. Epub 2016 Aug 23.

Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis.地舒单抗可预防侵蚀性类风湿关节炎患者掌骨干皮质骨丢失。

Arthritis Care Res (Hoboken). 2010 Apr;62(4):537-44. doi: 10.1002/acr.20172.

Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial.地诺单抗对日本类风湿性关节炎患者的影响：一项在接受甲氨蝶呤治疗的类风湿性关节炎患者中进行的AMG 162（地诺单抗）剂量反应研究，以验证对骨侵蚀的抑制作用（DRIVE）——一项为期12个月的多中心、随机、双盲、安慰剂对照的II期临床试验。

Ann Rheum Dis. 2016 Jun;75(6):983-90. doi: 10.1136/annrheumdis-2015-208052. Epub 2015 Nov 19.

Role of denosumab in bone erosions in rheumatoid arthritis.地舒单抗在类风湿关节炎骨侵蚀中的作用。

Postgrad Med J. 2023 Aug 22;99(1175):976-984. doi: 10.1093/postmj/qgad013.

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.地诺单抗对类风湿关节炎结构损伤、骨密度和骨转换的治疗效果：一项为期十二个月的多中心、随机、双盲、安慰剂对照的II期临床试验。

Arthritis Rheum. 2008 May;58(5):1299-309. doi: 10.1002/art.23417.

Repair of Bone Erosion in Rheumatoid Arthritis by Denosumab: A High-Resolution Peripheral Quantitative Computed Tomography Study.地舒单抗治疗类风湿关节炎骨侵蚀：高分辨率外周定量计算机断层扫描研究。

Arthritis Care Res (Hoboken). 2017 Aug;69(8):1156-1163. doi: 10.1002/acr.23133. Epub 2017 Jul 10.

Efficacy of denosumab with regard to bone destruction in prognostic subgroups of Japanese rheumatoid arthritis patients from the phase II DRIVE study.来自 II 期 DRIVE 研究的日本类风湿关节炎患者预后亚组中地舒单抗对骨质破坏的疗效。

Rheumatology (Oxford). 2019 Jun 1;58(6):997-1005. doi: 10.1093/rheumatology/key416.

Denosumab for joints and bones.地诺单抗用于关节和骨骼。

Curr Rheumatol Rep. 2009 Jul;11(3):196-201. doi: 10.1007/s11926-009-0027-z.

Denosumab significantly improves bone mineral density with or without bisphosphonate pre-treatment in osteoporosis with rheumatoid arthritis : Denosumab improves bone mineral density in osteoporosis with rheumatoid arthritis.在类风湿关节炎相关性骨质疏松症中，无论是否进行双膦酸盐预处理，地诺单抗均可显著提高骨密度：地诺单抗可提高类风湿关节炎相关性骨质疏松症的骨密度。

Arch Osteoporos. 2017 Sep 21;12(1):80. doi: 10.1007/s11657-017-0371-y.

引用本文的文献

Erythrocyte membrane camouflaged celastrol and bilirubin self-assembly for rheumatoid arthritis immunotherapy based on STING inhibition and RONS clearance.基于STING抑制和活性氧氮物种清除的红细胞膜伪装雷公藤红素与胆红素自组装用于类风湿性关节炎免疫治疗

J Nanobiotechnology. 2025 Apr 26;23(1):318. doi: 10.1186/s12951-025-03389-9.

Changes in bone turnover markers and bone modulators during abatacept treatment.在阿巴西普治疗期间，骨转换标志物和骨调节剂的变化。

Sci Rep. 2023 Oct 11;13(1):17183. doi: 10.1038/s41598-023-44374-2.

Personalized Therapeutic Strategies in the Management of Osteoporosis in Patients with Autoantibody-Positive Rheumatoid Arthritis.自身抗体阳性类风湿关节炎患者骨质疏松症管理中的个性化治疗策略

J Clin Med. 2022 Apr 22;11(9):2341. doi: 10.3390/jcm11092341.

The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders.内分泌激素在不同关节炎性疾病中的新作用。

Front Endocrinol (Lausanne). 2021 May 21;12:620920. doi: 10.3389/fendo.2021.620920. eCollection 2021.

Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment.炎症性关节炎中的骨质疏松症：发病机制与治疗的新视角

Front Med (Lausanne). 2020 Dec 1;7:613720. doi: 10.3389/fmed.2020.613720. eCollection 2020.

The impact of long-term biologics/target therapy on bone mineral density in rheumatoid arthritis: a propensity score-matched analysis.长期生物制剂/靶向治疗对类风湿关节炎患者骨密度的影响：倾向评分匹配分析。

Rheumatology (Oxford). 2020 Sep 1;59(9):2471-2480. doi: 10.1093/rheumatology/kez655.

Osteoporosis in Rheumatic Diseases.风湿性疾病相关的骨质疏松症

Int J Mol Sci. 2019 Nov 22;20(23):5867. doi: 10.3390/ijms20235867.

Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates.地诺单抗对从双膦酸盐转换治疗的类风湿关节炎患者骨密度和骨转换标志物的影响。

J Exp Orthop. 2019 Oct 29;6(1):41. doi: 10.1186/s40634-019-0211-7.

Bone erosions in rheumatoid arthritis: recent developments in pathogenesis and therapeutic implications.类风湿关节炎中的骨侵蚀：发病机制的最新进展及治疗意义

J Musculoskelet Neuronal Interact. 2018 Sep 1;18(3):304-319.

Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naïve rheumatoid arthritis.生物制剂初治类风湿关节炎患者换用地舒单抗或每日特立帕肽对影像学关节破坏进展的影响。

Osteoporos Int. 2018 Jul;29(7):1627-1636. doi: 10.1007/s00198-018-4492-y. Epub 2018 Mar 24.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验